LEOCLAN Co.,Ltd. (TYO:7681)
Japan · Delayed Price · Currency is JPY 932.00
-20.00 (-2.10%)
Feb 17, 2026, 9:01 AM JST
LEOCLAN Revenue
LEOCLAN had revenue of 10.37B JPY in the quarter ending December 31, 2025, with 227.09% growth. This brings the company's revenue in the last twelve months to 28.69B, up 63.36% year-over-year. In the fiscal year ending September 30, 2025, LEOCLAN had annual revenue of 21.49B with 8.51% growth.
Revenue (ttm)
28.69B
Revenue Growth
+63.36%
P/S Ratio
0.19
Revenue / Employee
185.10M
Employees
155
Market Cap
5.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 21.49B | 1.69B | 8.51% |
| Sep 30, 2024 | 19.80B | -6.83B | -25.64% |
| Sep 30, 2023 | 26.63B | -3.14B | -10.53% |
| Sep 30, 2022 | 29.77B | 3.42B | 12.98% |
| Sep 30, 2021 | 26.35B | 4.35B | 19.78% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Care Twentyone | 48.16B |
| Living Platform,Ltd. | 20.71B |
| Sapporo Clinical Laboratory | 20.39B |
| Shigematsu Works | 14.87B |